Asset
SAB-185
SAB Biotherapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04469179 | phase1 | unknown | 2020-08-20 | 2021-02-25 | SAb Biotherapeutics, Inc. | Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 |
| NCT04468958 | phase1 | completed | 2020-07-01 | 2020-12-23 | SAb Biotherapeutics, Inc. | Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants |
FDA applications (0)
This company has no applications containing this asset.